NMPA Approval

Emtricitabine and Tenofovir Disoproxil Fumarate Tablets

Approval Number

国药准字HJ20200025

Registration Date

April 25, 2022

Previous Approval Numbers

国药准字HJ20200025

Drug Information

Generic Name

恩曲他滨替诺福韦片

Trade Name

舒发泰

Brand Name

舒发泰

Dosage Form

片剂

Strength

200mg的恩曲他滨,300mg的富马酸替诺福韦二吡呋酯

Drug Type

化学药品

Registration Date

April 25, 2022

Expiry Date

April 24, 2027

Company Address

333 Lakeside Dr, Foster City, CA 94404 United States of America

Company NamePatheon Inc

Company Address

2100 Syntex Court, Mississauga, Ontario L5N 7K9 CANADA

Empowering clinical research with data-driven insights and AI-powered tools.

恩曲他滨替诺福韦片 - NMPA 批准文号 | MedPath